“What I like, I eat. I don’t know how long I’m going to live”

This transaction values Clover at an enterprise value of $3.7 billion and is expected to provide up to $1.2 billion in cash proceeds, including a fully committed PIPE of $400 million and up to $828 million of cash held in the trust account of Social Capital Hedosophia Holdings.

The expansion comes on the heels of Clover’s most significant year of customer growth to date.

has launched Clover Therapeutics, a research subsidiary focused on developing medicines for older adults. Clover Therapeutics also announced it entered into...